// App-Quantinova.ai

11008 : Integrative assessment of expression and prognostic value of PDL1, IDO, and kynurenine in 371 primary soft tissue sarcomas with genomic complexity.

Researchers

Presenter

  • Maud Toulmonde

Principal Investigators

  • Julien Adam

  • Alban Bessede

  • Dominique Ranchere-Vince

  • Valerie Velasco

  • Veronique Brouste

  • Jean-Yves Blay

  • Olivier Mir

  • Antoine Italiano

Medical Centers

  • Institut Bergonie, Department of Medical Oncology, Bordeaux, France

  • Department of Biopathology. Gustave Roussy Cancer Campus, Villejuif, France

  • ImmuSmol, Pessac, France

  • Centre Leon Berard, Department of Pathology, Lyon, France

  • Institut Bergonie, Department of Imaging, Bordeaux, France

  • Institut Bergonie, Department of Imaging, Bordeaux, France

  • University Claude Bernard Lyon I, Centre Leon Berard, Lyon, France

  • Gustave Roussy, Villejuif, France

Locations

  • France

Companies

  • N/A

Study Components

Therapeutic Area

  • Genetic Disorder

  • Musculoskeletal

Disease

  • Sarcoma

  • Short stature, onychodysplasia, facial dysmorphism, and hypotrichosis

Biomarkers

  • Programmed death-ligand 1

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved